Cardiovascular Risk Stratification in Patients With Obstructive Sleep Apnea

Associacao Fundo de Incentivo a Psicofarmcologia2,000 enrolled

Overview

The purpose of this study is: 1. To determine the frequency of cardiovascular diseases in patients with OSA, obese, overweight, and lean (BMI\<25) 2. To analyze the CPAP treatment over the clinical evolution of OSA patients 3. To determine if OSA is a independent predictor of cardiovascular risk

Obstructive Sleep Apnea (OSA) is a condition with important cardiovascular repercussions. However, the association between OSA, cardiovascular diseases, and obesity has not been totally clarified. We hypothesized that the cardiovascular consequences of OSA are due to obesity.

Study Type

OBSERVATIONAL

Enrollment

2,000

Conditions

Obstructive Sleep Apnea Obesity

Eligibility

Sex: ALLMin age: 30 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Men and women with OSA (apnea-hypopnea index higher than 5 events/hour) Exclusion Criteria: * Body mass index higher than 40

Locations (1)

Instituto do Sono/AFIP

São Paulo, São Paulo, Brazil

RECRUITING

Outcomes

Primary Outcomes

Cardiovascular events

Time frame: five years

Central Contacts

Fatima D Cintra, MD, PhD

CONTACT

55 11 99698555 fatimacintra@interair.com.br

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.